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Telemedicine was introduced in the U.S. in the
late 1950s when the Bureau of Indian Affairs
used telephone and video programs to
train paramedics who resided on indian reser-
vations (1). Despite technological advances
that have greatly expanded the potential appli-
cations of telecommunication, telemedicine
has developed slowly in the U.S. where issues
such as physician acceptance, federal regula-
tion of Medicare/Medicaid reimbursement,
other third party reimbursement, and state reg-
ulation of medical licensure have impeded
widespread adoption (2).  Two recent reviews
of the use of telemedicine in the U.S. suggest
that only 50 - 80 telemedicine programs con-
duct interactive consultation (1,2). Radiology,
Cardiology, Dermatology, and Psychiatry are
the specialties that have used telemedicine
most extensively (2).
Telemedicine has been incorporated into vari-
ous correctional healthcare systems and
appears to meet with physician and patient
satisfaction and to reduce costs that are asso-
ciated with travel and security for inmate
healthcare. Although a comprehensive review
of the literature is beyond the scope of this arti-
cle, selected published information regarding
the use of telemedicine in prisons has been
reviewed and summarized. In addition, this
article will highlight the development of a
telemedicine clinic for HIV care in the Texas
Department of Criminal Justice.
Telemedicine in Prisons
Literature Review
The experience of seven correctional jurisdic-
tions’ use of telemedicine for inmate health-
care has been reported. Most of these reports
describe a pilot or feasibility study in which
telemedicine was incorporated into the existing
correctional healthcare system. Since primary
medical care is provided at the correctional
unit, telemedicine has been used for specialty
or subspecialty consultation. In most cases,
telemedicine has replaced specialty/subspe-
cialty care that had been provided at a distant
location, most commonly at a university med-
ical center. None of the reports compare spe-
cific health outcomes of care delivered in a tra-
ditional clinic visit versus care delivered via
telemedicine. In general, patients and prov-
iders have been satisfied with their respective
telemedicine experiences. According to the
reports, six out of seven systems indicated that
reductions in travel and security for inmate
healthcare costs have had a positive financial
impact.  See Heppigram on page 6 for details
of each correctional jurisdiction’s experience
with telemedicine.
Telemedicine for HIV Care in
the Texas Department of
Criminal Justice
In 1997 there were approximately 2,000 identi-
fied HIV+ inmates in the TDCJ. Most were
housed in the eastern sector of the state.
University of Texas Medical Branch Galveston
has a managed healthcare contract to provide
both primary and specialty care to inmates
who are housed in the eastern sector of the
state.  This area covers 134,000 square miles
(approximately half the area of the state) and
contains 69 correctional facilities.  Prior to the
If you have any problems with this fax transmission please call 877.896.7636 or e-mail us at ccg@ccgnetwork.com
Continued on page 2
WHATS INSIDE
Spotlight pg 5
HEPPigram pg 6
Save The Dates pg 7
HIV 101 pg 8
Self-Assessment Test pg 9  
David Paar, M.D.*
Director, AIDS Care and Clinical Research Program,
University of Texas Medical Branch at Galveston
Two recent reviews of the use of
telemedicine in the U.S. suggest that
only 50-80 telemedicine programs
conduct interactive consultation.
introduction of telemedicine for HIV health-
care, inmates traveled to UTMB Galveston
for HIV clinic which is conducted one day
per week in the TDCJ Inpatient/Outpatient
Hospital located on the UTMB campus.
Because of the distances involved, inmate
travel can take up to a week each way and
involves nightly stays at several transfer
units along the way.  Like the other systems
that delivered specialty care at a central
location, the cost of transportation and
associated security for healthcare-related
travel was enormous.
Since time and space in the Galveston
Inpatient/Outpatient Prison Hospital facility
are limited, only one day per week could be
assigned for HIV care.  An average of 100
inmates were seen weekly, and due to a
limited number of medical providers, the
clinic day often stretched to 10 - 12 hours,
which incurred additional operation costs
for overtime for clinic staff and ancillary
healthcare providers.  By the end of the
day, morale among providers, support staff,
and patients was low.
Inmates also had valid concerns related to
their healthcare.  When they are away from
their unit of assignment overnight, they risk
losing their cell or dormitory bed.  Their
possessions (which are often numerous for
those with long sentences) have to be
turned over to security for safekeeping dur-
ing their absence, nonetheless; many
inmates report that possessions are lost on
their return.  While provisions have been
made to stock transfer units with all anti-
retroviral medications, the truth is that
doses of medications are often missed dur-
ing stays at transfer units.  For all of these
reasons, some inmates refused to travel for
HIV-related healthcare or refused to return
to clinic as frequently as the providers felt
was necessary. 
UTMB Correctional Managed Care made a
commitment in the early 1990s to develop
telemedicine for correctional healthcare.  A
large telecommunication network that links
12 remote sites with the primary site for
specialty healthcare in Galveston was
installed. The 12 remote sites are hubs that
are in proximity to surrounding correctional
units so that telemedicine may still involve
inmate travel, but travel back and forth to
each of the hubs takes less than a day alto-
gether.  In 1997, subspecialty services
were mandated to develop telemedicine
clinics.  
During planning for the HIV telemedicine
clinic, the following provider issues were
raised:  
l Could an adequate provider-patient rela-
tionship be established or maintained via
telemedicine?  
l Could patient confidentiality be main-
tained during telemedicine encounters?  
l  If telemedicine was judged inadequate for
a particular patient, would TDCJ Managed
Care certify a Galveston HIV Clinic visit to
address the patient’s healthcare needs?  
The patient-provider issue had to wait until
telemedicine encounters commenced for
resolution. In regard to the other issues,
it was determined that confidentiality
remained the responsibility of healthcare
providers and ancillary support staff used to
conduct telemedicine [for a review of tele-
health confidentiality issues, see Stone,
1999] (12). UTMB Managed Care also rec-
ognized that not all health issues could be
addressed using telemedicine, so there
was no issue with precertification for onsite
visits following a telemedicine encounter
that was deemed inadequate for effective
healthcare.  
One system issue related to unit level
laboratory capabilities also had to be
addressed. At most TDCJ correctional
units, blood specimens for laboratory tests
are collected and processed at the units
and then transported by an established
courier system to UTMB Galveston where
the tests are performed.  Prior to 1997,
inmates had to travel to Galveston for viral
load testing since laboratory personnel
were not trained to process viral load spec-
imens and courier vans did not have the
equipment to properly store specimens dur-
ing  transport to Galveston.  This was
addressed by training unit level laboratory
personnel to process viral load specimens
and by purchasing temperature controlled
transport units for the courier vans.
Tasks necessary to conduct telemedicine
clinics efficiently were identified and
assigned to specialists and to unit
providers. HIV specialists designed data
collection forms that would capture all of
the clinical and laboratory data necessary
to make HIV-related medical decisions.
Unit providers would collect available data
prior to the telemedicine encounter and fax
this information to the Galveston site prior
to the encounter. Galveston HIV specialists
were responsible for initiating and changing
antiretroviral therapy and were available for
telephone consultation as necessary by the
unit providers. Unit providers were respon-
sible for monitoring ongoing antiretroviral
therapy for adherence, toxicity, and efficacy
and to make indicated interventions to
improve adherence or treat side effects.
Since unit providers were being asked to
actively participate in HIV care, a three-day
"HIV Minifellowship for Correctional Care
Providers" was developed and is conduct-
ed two to three times per year.  Course fac-
ulty are the UTMB HIV specialists who take
advantage of the opportunity to establish a
professional working relationship as well as
to provide education. 
HIV telemedicine clinics are conducted
once per week and are staffed at the pri-
mary site in Galveston by a physician,
physician assistant, two clerical staff, a clin-
ical pharmacist to help review compliance
and other drug-related issues, and a
research nurse who may verbally screen
appropriate patients for participation in clin-
ical trials. The remote site is staffed by
the presenter (usually an R.N.) with appro-
priate clerical and security support.
Equipment at both sites includes video
and sound equipment, a FAX machine,
and computers which are used to access
electronic data that both systems share
(primarily laboratory data and healthcare
appointment data). Completed medical
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Because of the distances
involved, inmate travel can take
up to a week each way and
involves nightly stays at several
transfer units along the way.
The remote site is staffed 
by the presenter (usually an
R.N.) with appropriate clerical
and security support. Equipment
at both sites includes video and
sound equipment, a FAX
machine, and computers which
are used to access electronic
data that both systems share.
Dear Colleagues,
In response to reader request, HEPP focuses on telemedicine this month. Dr. David Paar,
Director, Director, AIDS Care and Clinical Research Program, University of Texas Medical Branch
at Galveston, provides a personal report on the establishment and evaluation of a telemedicine
program targeting HIV treatment for the Texas DOC. While his experience has been favorable,
some concerns about telemedicine have been raised by other correctional HIV providers. My own
reaction to telemedicine has been tinged with concern; will long range video ever be able to recre-
ate the private conversation that occurs between patient and physician in the HIV clinic? Dr. Paar
believes that close up shots can recreate a sense of privacy. However, I imagine some of the visu-
al cues that I use to evaluate patients might be lost - the subtle shifting in a chair that comes when
adherence is being discussed, that clues me into the possibility that the patient is not giving accu-
rate information. For example, will patients be as willing to address their life issues, their histories
of substance abuse, their violent domestic relationships with me on a video monitor? These are
all components of my HIV treatment interviews, since they provide the framework within which
adherence to HIV medication will need to take place (post release). I also imagine that my dis-
cussions with patients about HIV prevention might not take place over a monitor; would my
patients be as forthcoming about their HIV risk behaviors?
Nevertheless, telemedicine addresses some of the major concerns that patients may have about
leaving their home facility for distant HIV specialty care centers. In states where the number of
inmates affected by HIV is high and specialty care sites are distant, telemedicine may be able to
bridge the gap between no specialty care and much improved care. And, consistent with my role
as an educational newsletter editor, I wholeheartedly support the use of telemedicine facilities for
increasing teaching opportunities- often described as tele-consultation involving case discussions
with providers on site. Increased communication with providers at remote sites will definitely
improve patient care.
Also in this month’s HEPP News is a report on HIV testing comparing standard serum assays
(EIA and Western blot) with other newer methodologies. One such methodology is in use in the
New York State DOC. Next month we’ll address another topic of great interest to our readers:
Hepatitis C. 
After reviewing this issue, readers should be able to list advantages and disadvantages of
telemedicine, distinguish the advantages of using different HIV diagnostic tests, and list the some
of latest findings concerning HIV and lung disease.
Thank you for your continued support of HEPP News. We look forward to hearing from you!
Sincerely,
Anne S. De Groot, M.D.
Letter from the Editor
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4data forms are faxed from the remote site to
Galveston prior to the encounter. The patient
encounter occurs, and the specialist writes a
clinic note with recommendations which is
faxed to the remote site for inclusion in the
medical record.  Follow up appointments are
requested at intervals deemed appropriate
by the HIV Specialist.
Experience has shown that patient-provider
relationships can be established and main-
tained with telemedicine. My personal obser-
vation is that close-up video shots of both
the patient and the provider are effective in
creating a sense of intimacy that is lacking
when long shots are used. The use of auxil-
iary cameras, for example a document cam-
era, can be used to present visual educa-
tional information such as pill charts and
viral replication cycles. This information can
then be faxed to the inmate. Formal provider
and patient satisfaction surveys have not
been completed, but the two physicians and
one physician assistant who conduct
telemedicine clinic feel it is effective in treat-
ing HIV and more efficient from a time
standpoint than specialty care delivered
onsite at Galveston. 
The first year of the Texas telemedicine
experience was reported and reviewed
above (11). Cost savings due to a reduction
in travel and security for inmate healthcare
were directly related to the total number of
telemedicine encounters. Comparison of
specific medical outcomes (i.e. number of
patients achieving nondetectable viral loads)
between telemedicine and onsite HIV care
have not been conducted, but the telemedi-
cine providers who also staff onsite HIV clin-
ic have not noted major differences in
progress between the two populations. In
1995, the number of deaths in HIV-positive
inmates peaked and then began to decline
in parallel with national trends in HIV-related
deaths. This trend has been attributed to
combination chemotherapy with protease
inhibitors and/or efavirenz. This trend has
continued through 1999, therefore; the intro-
duction of telemedicine did not affect this
gross measure of overall HIV care.
In 1999, a "teleconsult" clinic for HIV care
was established.  In this clinic, unit providers
perform patient encounters and collect clini-
cal and laboratory data that is necessary for
medical decision making on forms that were
designed by the HIV specialists. This infor-
mation is faxed to the specialist prior to tele-
consult clinic. During the clinic, the specialist
and the unit provider use telecommunication
equipment to develop a plan for HIV care.
Both providers have the patient’s medical
chart for review of information that is perti-
nent, but not easily summarized on data col-
lection forms. This method of healthcare
delivery works best when unit providers are
highly motivated to participate and have
attended the "HIV Minifellowship for
Correctional Healthcare Providers" so that
minimal baseline HIV knowledge has been
established. 
Conclusion
A potentially promising expansion of
telemedicine in correctional  settings would
be to use it for discharge planning and link-
age to community-based services. For
example, telemedicine could be used for
inmates to "meet" and establish rapport with
community-based providers prior to being
released, thereby increasing the likelihood
that  releasees would actually obtain needed
services in the community.
At the TDCJ, telemedicine allowed a notable
reduction in overall healthcare costs. Since
its establishment last year, the Teleconsult
Health Clinic at TDCJ appears to be deliver-
ing effective HIV healthcare. Anecdotally,
providers and patients seem to be satisfied
with telemedicine encounters and medical
outcomes between the clinics appear to be
similar.
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expansion of telemedicine in 
correctional settings would be 
to use it for discharge 
planning and linkage to 
community-based services.
Telemedicine
in Practice... 
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Remembering Dr. Armond Start 1931-2000
by Dr. Joseph Paris, M.D., Georgia Department of Corrections Medical Director, 
President, Society of Correctional Physicians
In 1987, I was a very green correctional physician giving my first national presentation
at an NCCHC meeting. I felt under scrutiny by the several seasoned correctional vet-
erans I saw in the audience. I plowed through my topic, PPD testing of refusing
inmates. In my inexperienced exuberance, I proposed to be in favor of public health
considerations and test aggressively. Armond startled a roomful of attendees with a
loud "I do not like what I am hearing here." His concern for the welfare and dignity of
incarcerated persons knew no bounds. Later in life, Armond and I met dozens of
times, became the best of friends, and sought one another at correctional meetings
and social functions. I consider him a most important mentor and adviser.  At the New
Orleans NCCHC Meeting this March, we shared memories of the old times and
laughed at his putting me in my place a long time ago. Upon reflecting about his long
professional life in corrections, he wished he had done more. I reassured him that few
people have done so much for inmate health care as he did. I am privileged to have
had Armond’s friendship and guidance.
Dr. Armond Start passed away unexpectedly on March 30, 2000 in Tulsa, Oklahoma.
With his passing, modern correctional health care lost one of its founding fathers and
strongest advocates.
Dr. Start began his career as a private pediatrician in Oklahoma City, OK.  In 1975, he
moved into the Communicable Disease Department for the State of Oklahoma, and in
1977, became the Medical Director of the Oklahoma Department of Corrections. From
there, Dr. Start went on to fill the same position for the States of Texas and Wisconsin
while consulting for the Department of Justice and many others in cases of litigation
and program improvement.
In 1991, in an attempt to improve the quality of healthcare in correctional facilities, Dr.
Start established the National Center for Correctional Health Care Studies at the
University of Wisconsin-Madison Medical School. This was the first program in the
country to offer a fellowship in the area of correctional healthcare.
Over the years, Dr. Start received many awards and accolades, including the Award of
Merit from the National Commission on Correctional Health Care. In 1998, the Society
of Correctional Physicians honored him by naming our first Award in his name, the
Armond Start Award.
Dr. Start was one of the principal organizers and founders of Society of Correctional
Physicians. It was his leadership that brought us all together to work for the causes he
held so dear, and this organization is a lasting tribute to his dedication. He was one
who truly cared about his fellow human being, especially those that our society incar-
cerates. Correctional Health Care has lost a giant of a man, a strong advocate and a
warm, humane caring individual with Dr. Starts passing. We will miss him dearly.
HIV  Testing: Oral Mucosal
Transudate (OMT) Technology
Oral Mucosal Transudate (OMT)  testing has
been shown to enhance access and accept-
ability of HIV testing in at-risk populations.
OMT testing finds twice as many HIV-infected
clients as serum-based testing.  While the
cost of an OMT test is slightly more expensive
than serum-based tests ($34.46 versus
$31.62), the cost for people who are seroneg-
ative is less ($16.16 versus $17.22).  Since
most tests find clients are negative, OMT test-
ing is ultimately cheaper than serum-based
testing. (Randall L.  Effectiveness of Oral
Mucosal Transudate HIV Testing: Findings
from Michigan’s’ Evaluation.  Abstract #690 in
1999 National HIV Prevention Conference.)
70 correctional facilities in New York State
currently use OMT. For more information, con-
tact the Infectious Disease Coordinator at the
New York Department of Corrections (518)
457-7072. 
Rifampin and Pyrazinamide
vs. Isoniazid TB Prevention in
HIV-infected patients
In the March 2000 issue of HEPP News, Elsa
Villarino of the CDC described the two-month
daily regimen of rifampin and pyrazinamide
(PZA) as treatment of tuberculosis in HIV-
infected persons. The March 15 issue of the
Journal of the American Medical Association
published results from an international study
that compared a two-month regimen of daily
rifampin and pyrazinamide with a 12-month
regimen of daily isoniazid to prevent tubercu-
losis (TB) in HIV-positive patients. Clinics in
the United States, Mexico, Haiti, and Brazil
recruited a total of 1,583 HIV-positive people
aged 13 or over who tested positive for TB.
After a follow-up of 37 months, the results
showed that a two-month course of daily
rifampin and pyrazinamide is similar in terms
of safety and efficacy to the 12-month isoni-
azid treatment for preventing TB in HIV
patients. Gordin, et. al., note the shorter regi-
men is an effective alternative that has advan-
tages for patients and TB control efforts,
especially in poorer areas with drug-resistant
patients.   (Gordin F et al. JAMA. 3/15/00;
283(11): 1445.)
Treatment News
It was his leadership that brought us all together to work 
for the causes he held so dear, and this organization is 
a lasting tribute to his dedication. He was one who 
truly cared about his fellow human being, especially those 
that our society incarcerates. Correctional Health Care 
has lost a giant of a man, a strong advocate 
and a warm humane caring individual with Dr. Starts passing.
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HEPPigram
Review of Published Reports of Telemedicine (TM) Use in Corrections in the U.S.
Correctional
Jurisdiction
Reasons TM
considered
Year TM 
initiated
# of 
encounters
Specialties/
subspecialties
participating
Academic 
affiliation of
specialists
Medical 
outcomes 
reported 
Provider 
satisfaction
Patient 
satisfaction
reported
Financial
impact of TM
reported?
California
DOC* (3)
Access to spe-
cialty care, cost
of travel and
security for
healthcare
1997
NR**
Psychiatry,
Gastroenterology
+ 14 others
NR
NR
NR
Other note:
Tele-
communication
equipment
being used for
grand rounds
No
No
Dade County, FL
Prison Medical
Services (4)
TM, addition of
PNPs***, and
onsite specialty
consultation were
parts of a plan to
impact cost and
quality of care
1975
NR
NR
University of
Miami
Unscheduled
return visits,
patient disability,
and mortality did
not change after
system changes
NR
NR
Addition of PNPs
to staff reduced
cost; TM
increased costs
since MD involved
in care
Georgia DOC
(5)
TM in prisons
was part of
statewide TM
network
designed to
bridge gaps in
health care in
remote and
rural areas
1977
95
Dermatology
Medical
College of
Georgia
NR
> 77 % of
physicians sat-
isfied with the
encounter,
video, and
sound
NR
NR
North Carolina
DOC (6,7)
Cost and risk of
inmate trans-
portation,
access to 
specialty care
1991
138
Dermatology
consultations
conducted
between 8/92
and 10/94
Dermatology +
37 other 
specialties
East Carolina
University
School of
Medicine
NR
Formal assess-
ment not done,
but most con-
sultants confi-
dent of their
diagnosis and
treatment plan
NR
Start up costs
and time to
maximize effi-
ciency of sys-
tem delayed
financial
rewards for
several years
Ohio Department of
Rehabilitation and
Corrections (8, 9 )
Cost of transportation
and security for 
healthcare, access to
specialty care
1995
131 encounters during
1995
NR
Ohio State University 
Medical Center
NR
24 providers who were
surveyed reported that
TM  was adequate for
patient encounters
Patient survey complet-
ed in 1996. 221/299
completed survey 
and all satisfied with
information exchanged
and patient comfort
During 1995, telemedi-
cine encounters reduced
inmate travel for health-
care by 98 %
Virginia DOC
(10)
Improved
healthcare, 
cost of trans-
portation for
healthcare
1994
165 HIV +
inmates seen
between 10/94
and 4/95
HIV, cardiolo-
gists, others
Medical
College of
Virginia (MCV)
NR
NR
NR
Cost of health
care decreases
from $497 per
encounter prior
to TM, $256
per encounter
after TM begins
Texas Department
of Criminal
Justice (11)
Access to specialty
care, cost of 
transportation 
and security for
healthcare
1992
1,715 patients 
seen between
October 1994 and
November 1995
All medical 
and surgical 
subspecialties,
Dermatology,
Neurology
The University of
Texas Medical
Branch at
Galveston
NR
576 inmates inter-
viewed following a
TM encounter; 69
% prefer TM over
travel for health-
care; 14 % have
no preference; and
17 % would rather
travel for health-
care
95 % of telemedi-
cine encounters
prevent an onsite
visit; cost per
encounter declines
and number of TM
encounters
increases
*DOC = Department of Corrections     **NR = not reported      ***PNP = Primary Nurse Practitioner
Management of HIV/ AIDS in the
Correctional Setting: A Live Satellite
Videoconference Series
Pulmonary Complications of 
HIV Infection 
June 6, 2000, 12:00-3:30pm
CME credit available
Call: 518.262.6864
Email: santosm@mail.amc.edu
HIV Prevention Strategies for
Incarcerated Populations
June 20, 2000
Central Maryland, MD 
Call: 410.328.8674
Fax: 410.328.9106
Email: sholland@
medicine.umaryland.edu
Fee: $20
A Strategy Meeting for Improving 
HIV and Hepatitis Care in 
Prisons and Jails
June 17, 2000
Washington DC
Contact Jackie Walker at the National
Prison Project of the ACLU. 
Call: 202-234-4830
Fax: 202-234-4890
Email: jckiewalk@aol.com
5th  New England Correctional Health
Care Conference: Integrating
Correctional and Public Health
June 28, 2000
Sturbridge, MA
Sturbridge Host Hotel & 
Conference Center
CME credit available.
Call: 781.890.3434
Fax: 781.890.2766
Email: chcc@icg-ps.com.
2000 American Correctional
Association (ACA) Summer Congress
August 14-16, 2000
San Antonio, TX
Call: 800.222.5646, ext. 1922 
Fax: 1-301-918-1900
Visit: www.corrections.com/aca
24th National Conference on
Correctional Health Care 
September 9-13, 2000 
St. Louis, MO
Cervantes Convention Center 
CME credit available.
Call: 773.880.1460
Fax: (773) 880-2424
Email: ncchc@ncchc.org
Visit: www.ncchc.org
HIV/AIDS Behind Bars
Call for Abstracts.
HEPP News is sponsoring a pre-confer-
ence colloquium at the NCCHC confer-
ence listed below that will discuss the
outcomes of HIV education and preven-
tion interventions in correctional settings.
Accepting 500-word abstracts until
August 7. Please fax or e-mail questions
to Matt Stark: fax: 401-863-1243;
matthew_stark@brown.edu.
Save the 
Dates
News Flashes
GAO Reports Inadequate 
HIV Care for Minorities
In an assessment of The Ryan White Care
Act and other AIDS assistance programs,
government auditors in the General
Accounting Office (GAO) concluded that
Blacks with AIDS are receiving inferior care
compared with whites. The GAO said that
Blacks, Hispanics and women with AIDS
make up the vast majority of people served
by local AIDS groups funded by a govern-
ment program. That statement must be quali-
fied, however, by recognizing that the federal
government emphasized distribution of funds
based on the number of full-blown AIDS
cases, instead of on the number of HIV-
infected people.  This observation indicates
that federal dollars should be redirected to
include funding for AIDS prevention, which
accounted for less than 10 percent of the
$10 billion in federal AIDS spending last year.
The findings come as research shows that
the AIDS epidemic is hitting minorities and
women hard. Blacks, who make up about 13
percent of the U.S. population, accounted for
49 percent of AIDS deaths in 1998, accord-
ing to the Centers for Disease Control.
Thirty-two percent of deaths were among
whites and 18 percent were among
Hispanics. The GAO audit also found that
rural areas may offer more limited medical
and social services than cities because
urban areas generally receive more money
per AIDS case. According to the audit, the
Department of Health and Human Services,
which administers the Ryan White Care Act
grants, agreed with most aspects of the GAO
report.  The full report is available at
www.gao.gov. (HIV/AIDS: Use of Ryan White
CARE Act and Other Assistance Grant
Funds.  General Accounting Office Report:
GAO/HEHS-00-54, Mar. 1, 2000). 
Intergenerational Transmission of
Violence: Research Summary
In a recent Lancet article, Richard
Neugebauer reviewed the latest literature
concerning the links between childhood
physical and sexual abuse and the long-term
effects on emotional development and social
functioning. According to Neugebauer, some
studies have found that childhood neglect
(excluding abuse), nearly doubled the risk of
arrest for a violent offense in adulthood.
Research has shown that mistreatment in
childhood, whether it is neglect or physical or
sexual abuse, is associated with aggressive
and criminal behavior as well as a number of
clinical syndromes and personality disorders
in adulthood.  Neugebauer urges further
research on adults as well as immediate
implementation of focused intervention pro-
grams for children and adolescents.
(Neugebauer R.  Lancet, April 1, 2000; 355:
1117). 
In other news, a report released on the same
date in the April issue of the American
Journal of Public Health provides data on
sexual abuse and women at risk or infected
with HIV. Cohen et. al. found that  the preva-
lence of any domestic violence among the
1,600 at-risk women studied was 66 percent
among those with HIV and 67 percent among
those without the virus. The abused women
were more likely to have used drugs at some
time, to have had a partner at risk for HIV, to
have had over 10 lifetime male partners, to
have traded sex for money or drugs, and to
have had forced sex with an HIV-positive
individual. (Cohen M, Deamant C, Barkan S,
et al. Domestic violence and childhood sexu-
al abuse in HIV-infected women and women
at risk for HIV. American J Public Health,
April 2000; 90 (40): 560.
(www.apha.org/news/publications/journal)). 
"Increased Susceptibility to
Pulmonary Emphysema Among
HIV-Seropositive Smokers"
In the March 7 issue of Annals of Internal
Medicine Online, researchers from Ohio
State University published their findings on
risk for emphysema among HIV-infected
patients who have not developed AIDS-relat-
ed pulmonary complications. The
researchers compared 114 HIV-infected indi-
viduals to a group of 44 HIV-negative con-
trols matched for smoking history and age.
Seventeen of the 114 HIV-positive subjects
presented emphysema, versus only one of
the HIV-negative individuals.  The
researchers suggest that HIV infection
seems to directly accelerate the process of
smoking-induced parenchymal lung damage.
(Diaz PT, King MA, Pacht ER, et al. Annals
Int Medicine Online March 7, 2000; 132; 369.
(www.acponline.org/journals/annals)).
June HEPP News
Main Article: Correctional Doctors Dilemma:
HCV & HIV Co-infection
HIV 101: Treatment Courses for HCV & HIV
Spotlight: The Role of Public Health in HCV
Treatment in Prisons and Jails
HEPPigram: An Algorithm for HCV Diagnosis
7May 2000     Volume 3, Issue 5 visit HEPP News online at www.hivcorrections.org
Coming Next Month . . .
DETECTION OF ANTIBODY IN SERUM OR PLASMA (Lancet 348: 176, 1996; Med Lett 29:81, 1997)
1. Enzyme immunoassay (EIA) followed by Western blot for confirmation.  
Current assay detects antibodies to both HIV-1 and HIV-2.
Purpose: For all high-risk groups; antibody becomes positive approximately two mos. post-disease acquisition in majority; six
mos. after infection, 95% pts. antibody-positive (AJM 102: 117, 1997)
Comments: Detects IgG, IgA & IgM antibody. EIA repeated for all pos. tests: repeated positives need Western blot confirma-
tion.  False positive EIAs rare; false positives reported in pts with autoimmune disease (positive ANA), EBV antibody, pos.
syphilis serology, and presence of antibodies to HTLV I/II.
Western blot positive requires detection of two or more antibodies to HIV; p24, Gp41, Gp 120/160. Rare false positives;
0.004% of all blood donors (JAMA 280: 1080, 1998); if uncertainty, order plasma quant. of HIV RNA by PCR ("viral load").
False neg. EIA antibody test occurs in 1/500,000 units of donated blood.  Causes: 1) window between HIV acquisition and
antibody response (2-6 mos.), 2) pts with agammaglobulinemia, 3) disease due to genetic variant HIV, HIV-1 divided into
types: M for major (10 subtypes) and O for others.  GpO strains are not detected by current standard antibody tests (Nature
Med 4: 1032, 1998). Ref. for GpO: Emerg Inf Dis 12:39, 1998.
2. Rapid detection methods: results available in 30 minutes or less.
Examples: Single use diagnostic systems (SUDS)
Purpose: When quick answer needed, e.g. test blood of source pt in occupational exposure. Pts. who may not comply with
return visit; ER, STD clinics.
Comments: High temperatures and inadequate centrifugation can cause false-positives.  Need to confirm positive test with
standard serology.  Does not detect HIV, GpO, or HIV-2.   Refs. AnIM 124:471 & 509, 1996; J Clin Micro 33: 2899, 1995.
3. Home test kits, e.g. Home Access (JAMA 280: 1699, 1998).
Purpose: Encourage individuals at risk to determine their antibody status. 
Convenient, Anonymity maintained.
Comments: Better described as home specimen collection systems. Patient pricks fingertip and blood spotted on filter paper.
Positives confirmed with standard antibody. Counseling included. Ref: Arch Int Med 157; 309, 1997.
DETECTION OF HIV-1 ANTIBODY IN OTHER BODY FLUIDS
1. Antibody in oral mucosal transudate (OraSure) (Ref: JAMA 277: 254, 1997)
Purpose: Major advantage is avoidance of need for a needlestick. Easy to use; 
collected by health care worker.
Comments: Test pad placed between cheek and gum for 2-5 mins. Collects oral mucosal transudate containing IgG antibody.
Confirmatory test is OraSure HIV-1 Western blot.
2. Antibody in urine (Sentinel or Calypte): HIV-1 Urine ELISA)
Purpose: Rapid-results in 2.5 hours. Like rapid tests, could be used 
on source blood if occupational exposure or in ERs, STD clinics.
Comments: Non-invasive and rapid turnaround time attractive. Positives confirmed with urine Western blot. Rare pt serum
antibody neg. & urine antibody pos. (Lancet 342: 1458, 1993). 
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Antibody Tests Commonly Used in HIV Diagnosis and Management
Sensitivity: 99.9%    Specificity: 99.9%
Sensitivity: 99.9%     Specificity: 99.6%
Cost: Approx. $9/test
Sensitivity: 100%     Specificity: 99.95%
Cost: Approx. $35-50, 3-7 days
Sensitivity: 99.9%     Specificity: 99.9%
Cost: $99 for 3-test kit. Takes 3 days.
Sensitivity: 99.7%     Specificity: 100%
Cost: 192-test kit $816
HIV TREATMENT WEBSITES:
HIV/AIDS Treatment Directory 
http://www.amfar.org/td
Medscape HIV/AIDS
http://hiv.medscape.com
Johns Hopkins AIDS Service
http://www.hopkins-AIDS.edu
JAMA HIV/AIDS Information Center
http://www.ama-assn.org/special/hiv
International Association of Physicians in AIDS Care (IAPAC)
http://www.iapac.org
AEGIS-AIDS Education Global Information System
http://www.aegis.com
National Institute of Allergy and Infectious Disease
http://www.niaid.nih.gov
Grant for Life Skills Education for Prisoners 
The U.S. Department of Education is offering grants for projects that provide life-skills training for state and local prisoners. The goal of the grant
program is to establish and operate projects to reduce recidivism though the improvement of the life skills needed to reintegrate adult prisoners into
society. In this round of funding, 15 grants will be awarded, with the maximum grant size of $475,000. Application deadline: May 30, 2000. 
For complete details, contact Jennifer Arnolds at 202.205.5621.
Resources
Self-Assessment Test for Continuing Medical Education Credit
Brown University School of Medicine designates this educational activity for 1 hour in category 1 credit toward the AMA Physicians
Recognition Award. To be eligible for CME credit, answer the questions below by circling the letter next to the correct answer to each of
the questions. A minimum of 70% of the questions must be answered correctly. This activity is eligible for CME credit through 
June 30, 2000. The estimated time for completion of this activity is one hour and there is no fee for participation.
1.  What are some of the challenges that Telemedicine brings to
correctional HIV care?
a) Increased overall cost
b) Reduced patient-provider personal contact
c) Increased cost per visit (due to costly technology)
d) Insufficient clinical and laboratory data collection
2.  The HIV-1 Antibody test with the highest specificity and 
sensitivity is:
a) Enzyme immunoassay/western blot
b) Rapid detectin methods
c) Home test kits
d) Oral mucosal transudate tests such as OraSure
e) Sentinel or Calypte
3.  Which of the following HIV diagnostic tests has been shown
to increase accessibility and acceptability among at-risk 
populations?
a) Enzyme immunoassay/western blot
b) Rapid detectin methods
c) Home test kits
d) Oral mucosal transudate tests such as OraSure
e) Sentinel or Calypte
Indicate true or false.
4. A two-month course of daily rifampin and pyrazinamide
is similar in terms of safety and efficacy to the 12-month isoniazid
treatment  for preventing TB in HIV patients.
5. Researchers suggest that HIV infection seems to 
directly accelerate the process of smoking-induced parenchymal
lung damage.
6. Researchers suggest that patients on HAART do not
progress to smoking-induced parenchymal lung damage 
significantly faster than patients who do not have HIV.
BROWN UNIVERSITY SCHOOL OF MEDICINE  OFFICE OF CONTINUING MEDICAL EDUCATION  BOX G-A2  PROVIDENCE, RI 02912
The Brown University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor 
continuing medical education activities for physicians.  
The use of the Brown University School of Medicine name implies review of the educational format and material only.  The opinions, 
recommendations and editorial positions expressed by those whose input is included in this bulletin are their own.  They do not represent or 
speak for the Brown University School of Medicine.
For Continuing Medical Education credit please complete the following and mail or fax to 401.863.2660
Be sure to print clearly so that we have the correct information for you.
Name __________________________________________________________________ Degree ____________________
Address ____________________________________________________________________________________________
____________________________________________________________________________________________________
City ____________________________________________________ State ________ Zip ________________________
Telephone ________________________________________________ Fax ______________________________________
HEPP News Evaluation
5 Excellent    4 Very Good    3 Fair    2 Poor    1 Very Poor
1. Please evaluate the following sections with respect to:
educational value clarity
Main Article 5  4  3  2  1   5  4  3  2  1   
HEPPigram 5  4  3  2  1   5  4  3  2  1   
HIV 101 5  4  3  2  1   5  4  3  2  1   
Spotlight 5  4  3  2  1   5  4  3  2  1   
Save the 5  4  3  2  1   5  4  3  2  1   
Dates
2. Do you feel that HEPP News helps you in your work?
Why or why not?
3. What future topics should HEPP News address?
4. How can HEPP News be made more useful to you?
5. Do you have specific comments on this issue?
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